Showing results (111-120 of 147) with videos related to
Sort By:
Pageof 15
Investigative and Clinical Urology|June 4, 2021
Expression of phosphorylated p21-activated kinase 4 is associated with aggressive histologic characteristics and poor prognosis in patients with surgically treated renal cell carcinomaHo Won Kang, Xuan Mei Piao, Hee Youn Lee, et al.Urologic Oncology|December 19, 2020
A prognostic immune predictor, HLA-DRA, plays diverse roles in non-muscle invasive and muscle invasive bladder cancerXuan-Mei Piao, Ho Won Kang, Pildu Jeong, et al.Oncology Letters|September 21, 2017
Expression levels of FGFR3 as a prognostic marker for the progression of primary pT1 bladder cancer and its association with mutation statusHo Won Kang, Ye-Hwan Kim, Pildu Jeong, et al.Clinical Genitourinary Cancer|March 25, 2018
Molecular Progression Risk Score for Prediction of Muscle Invasion in Primary T1 High-Grade Bladder CancerHo Won Kang, Sung Pil Seo, Young Joon Byun, et al.Investigative and Clinical Urology|April 9, 2021
Urinary microRNA-1913 to microRNA-3659 expression ratio as a non-invasive diagnostic biomarker for prostate cancerYoung Joon Byun, Xuan Mei Piao, Pildu Jeong, et al.Prostate International|October 26, 2020
Parathyroid hormone is associated with prostate cancerWon Tae Kim, Woo Jin Bang, Sung Pil Seo, et al.Journal of Korean Medical Science|May 18, 2019
Methylation Signature for Prediction of Progression Free Survival in Surgically Treated Clear Cell Renal Cell CarcinomaHo Won Kang, Hongyong Park, Sung Pil Seo, et al.Investigative and Clinical Urology|May 18, 2019
Trends in clinical, operative, and pathologic characteristics of surgically treated renal mass in a Korean center: A surgical series from 1988 through 2015Ho Won Kang, Sung Pil Seo, Won Tae Kim, et al.Journal of Korean Medical Science|November 9, 2016
Impact of Young Age at Diagnosis on Survival in Patients with Surgically Treated Renal Cell Carcinoma: a Multicenter StudyHo Won Kang, Sung Pil Seo, Won Tae Kim, et al.Journal of Cancer Research and Clinical Oncology|October 14, 2019
The age-adjusted Charlson comorbidity index as a predictor of overall survival of surgically treated non-metastatic clear cell renal cell carcinomaHo Won Kang, Sung Min Kim, Won Tae Kim, et al.Pageof 15